Difference between revisions of "Sertznig P, et al. Dermatol. Endocrinol. (2011) cited as Ref 383 in DOI: 10.1038/s41392-020-0110-5 (Q9646)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 3, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): 130-135, #quickstatements; #temporary_batch_1590074839150) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / title | |||
| + | Peroxisome proliferator-activated receptors (PPARs) in dermatology: challenge and promise (English) | ||
| Property / title: Peroxisome proliferator-activated receptors (PPARs) in dermatology: challenge and promise (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 130-135 | ||
| Property / Page(s): 130-135 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:39, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Sertznig P, et al. Dermatol. Endocrinol. (2011) cited as Ref 383 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Sertznig P
0 references
Reichrath J
0 references
2011
0 references
Dermatol. Endocrinol.
0 references
3
0 references
Peroxisome proliferator-activated receptors (PPARs) in dermatology: challenge and promise (English)
0 references
130-135
0 references
